SMMT vs. PHM
SMMT (Summit Therapeutics Inc.) and PHM (PulteGroup, Inc.) are both stocks. SMMT operates in Biotechnology (Healthcare), while PHM operates in Residential Construction (Consumer Cyclical). Over the past 10 years, SMMT returned 6.37%/yr vs 21.69%/yr for PHM. At a 0.14 correlation, their price movements are largely independent.
Performance
SMMT vs. PHM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SMMT achieves a -15.15% return, which is significantly lower than PHM's 1.03% return. Over the past 10 years, SMMT has underperformed PHM with an annualized return of 6.37%, while PHM has yielded a comparatively higher 21.69% annualized return.
SMMT
- 1D
- -1.53%
- 1M
- -15.39%
- YTD
- -15.15%
- 6M
- -21.11%
- 1Y
- -24.13%
- 3Y*
- 99.82%
- 5Y*
- 13.15%
- 10Y*
- 6.37%
PHM
- 1D
- 0.86%
- 1M
- 0.21%
- YTD
- 1.03%
- 6M
- -7.17%
- 1Y
- 16.98%
- 3Y*
- 20.34%
- 5Y*
- 16.85%
- 10Y*
- 21.69%
SMMT vs. PHM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SMMT Summit Therapeutics Inc. | -15.15% | -1.99% | 583.72% | -38.59% | 57.99% | -42.77% | 193.75% | 39.13% | -89.62% | 29.44% |
PHM PulteGroup, Inc. | 1.03% | 8.54% | 6.22% | 128.76% | -19.22% | 34.03% | 12.55% | 51.33% | -20.76% | 83.43% |
Correlation
The correlation between SMMT and PHM is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.26 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.24 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Mar 6, 2015 | 0.14 |
The correlation between SMMT and PHM shifts across timeframes, from 0.14 (all time) to 0.26 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
SMMT:
$11.51B
PHM:
$22.92B
SMMT:
-$1.60
PHM:
$10.36
SMMT:
21.08
PHM:
1.77
SMMT:
$0.00
PHM:
$16.83B
SMMT:
-$83.36K
PHM:
$4.39B
SMMT:
-$738.34M
PHM:
$2.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SMMT vs. PHM — Risk / Return Rank
SMMT
PHM
SMMT vs. PHM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Summit Therapeutics Inc. (SMMT) and PulteGroup, Inc. (PHM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SMMT | PHM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.82 | ||
| Sortino ratioReturn per unit of downside risk | -1.01 | ||
| Omega ratioGain probability vs. loss probability | 1.00 | 1.12 | -0.11 |
| Calmar ratioReturn relative to maximum drawdown | -0.46 | 0.75 | -1.21 |
| Martin ratioReturn relative to average drawdown | -0.71 | 1.49 | -2.21 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SMMT | PHM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.32 | 0.50 | -0.82 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.07 | 0.49 | -0.42 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.04 | 0.60 | -0.55 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.02 | 0.26 | -0.23 |
Drawdowns
SMMT vs. PHM - Drawdown Comparison
The maximum SMMT drawdown since its inception was -95.75%, roughly equal to the maximum PHM drawdown of -92.40%. Use the drawdown chart below to compare losses from any high point for SMMT and PHM.
Loading charts...
Drawdown Indicators
| SMMT | PHM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.75% | -92.40% | -3.35% |
Max Drawdown (1Y)Largest decline over 1 year | -52.76% | -22.60% | -30.16% |
Max Drawdown (3Y)Largest decline over 3 years | -62.26% | -38.01% | -24.25% |
Max Drawdown (5Y)Largest decline over 5 years | -91.78% | -38.01% | -53.77% |
Max Drawdown (10Y)Largest decline over 10 years | -95.75% | -62.11% | -33.64% |
Current DrawdownCurrent decline from peak | -59.56% | -19.72% | -39.84% |
Average DrawdownAverage peak-to-trough decline | -57.64% | -35.49% | -22.15% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 34.02% | 11.38% | +22.64% |
Volatility
SMMT vs. PHM - Volatility Comparison
Summit Therapeutics Inc. (SMMT) has a higher volatility of 22.53% compared to PulteGroup, Inc. (PHM) at 7.75%. This indicates that SMMT's price experiences larger fluctuations and is considered to be riskier than PHM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SMMT | PHM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.53% | 7.75% | +14.78% |
Volatility (6M)Calculated over the trailing 6-month period | 56.78% | 23.18% | +33.60% |
Volatility (1Y)Calculated over the trailing 1-year period | 75.97% | 33.97% | +42.00% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 185.11% | 34.63% | +150.48% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 144.61% | 36.45% | +108.16% |
Dividends
SMMT vs. PHM - Dividend Comparison
SMMT has not paid dividends to shareholders, while PHM's dividend yield for the trailing twelve months is around 0.81%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PHM PulteGroup, Inc. | 0.81% | 0.78% | 0.75% | 0.66% | 1.34% | 1.00% | 1.16% | 1.16% | 1.46% | 1.08% | 1.96% | 1.85% |
SMMT Summit Therapeutics Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
SMMT vs. PHM - Financials Comparison
This section allows you to compare key financial metrics between Summit Therapeutics Inc. and PulteGroup, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SMMT and PHM have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SMMT has higher volatility (22.53%) compared to PHM (7.75%). In terms of maximum drawdown, SMMT dropped -95.75% vs PHM's -92.40%.
PHM currently has the higher Sharpe Ratio (0.50 vs -0.32), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SMMT and PHM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer